The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ANCHOR (OP-104): Melflufen plus dexamethasone (dex) and bortezomib (BTZ) in relapsed/refractory multiple myeloma (RRMM)—Optimal dose, updated efficacy and safety results.
 
Roman Hajek
Consulting or Advisory Role - Abbvie; Amgen; BMS; Celgene; Janssen-Cilag; Novartis; PharmaMar; Takeda
Speakers' Bureau - Amgen; Takeda
Research Funding - Amgen (Inst); BMS (Inst); Celgene (Inst); Novartis (Inst); Takeda (Inst)
 
Luděk Pour
No Relationships to Disclose
 
Miquel Granell
No Relationships to Disclose
 
Vladimir Maisnar
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Sanofi; The Binding Site
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Sanofi; The Binding Site
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Stefan Norin
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Malin Sydvander
Employment - Medivir; Oncopeptides
 
Jakob Obermüller
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Enrique M. Ocio
Honoraria - Amgen; Asofarma; Bristol-Myers Squibb; Janssen; MSD; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Mundipharma; Oncopeptides; Sanofi; Secura Bio; Takeda
Speakers' Bureau - Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Array BioPharma (Inst); Celgene (Inst); IDP Pharmaceuticals (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen; Sanofi; Takeda